Children With Type 1 Diabetes May Benefit From Very Low Carbohydrate Diates, Landmark Registry Study Suggests

One of the largest investigations ever conducted into dietary management of type 1 diabetes in childhood has delivered findings that could reshape long-held assumptions about how young patients should eat. Very low carbohydrate diets, followed by children as young as one year old, were associated with better blood sugar control, lower insulin requirements and healthier weight trajectories, without any detectable increase in severe metabolic complications or any measurable effect on growth. The research, presented at the annual meeting of the European Association for the Study of Diabetes in Milan, drew on a quarter of a century of data from a German prospective follow-up registry and involved more than 45,000 children living with the condition.

Type 1 diabetes is an autoimmune disease in which the insulin-producing beta cells of the pancreas are destroyed, meaning patients must rely on externally administered insulin for life. Because carbohydrate is the macronutrient with the most direct influence on blood glucose, the amount of carbohydrate a patient consumes has always been a central variable in insulin dosing. Conventional dietary guidance has generally encouraged moderate or higher carbohydrate intake combined with carefully matched insulin, partly out of concern that severe carbohydrate restriction could provoke dangerous metabolic disturbances in growing children. Yet in recent years a growing number of parents have begun experimenting with low and very low carbohydrate feeding strategies, often reporting striking improvements in their children’s glucose readings and a marked reduction in the amount of insulin needed each day.

Professor Christian Denzer, of the Department of Paediatrics and Adolescent Medicine, Division of Paediatric Endocrinology and Diabetes, at University Medical Center Ulm in Germany, who led the research together with Dr Belinda Lennerz of Boston Children’s Hospital and Harvard Medical School, explained the motivation behind the study. These diets are becoming more popular among people with diabetes, he noted, because patients themselves notice encouraging results, including much better blood sugar control and lower insulin needs. At the same time, he acknowledged that theoretical safety concerns have persisted, including the possibility of nutrient deficiencies, elevated cholesterol, low blood sugar episodes and ketoacidosis, a life-threatening complication of diabetes. In children, there is the additional worry that any restrictive diet could interfere with growth during critical developmental windows.

Until now, the evidence base for such diets in paediatric type 1 diabetes has been thin. Several observational studies and small interventional trials have corroborated the remarkable benefits on blood sugar and insulin requirements that patients report anecdotally, and no major safety events have been published to date. An earlier observational study led by Dr Lennerz, involving 316 children and adults, found major glycaemic benefits with mixed effects on cholesterol and no apparent adverse effect on growth or acute diabetes complications. But those studies were too small and too short to settle the question. What was needed, the researchers argued, was a large, long-term analysis capable of detecting rare complications and subtle effects on growth across a broad paediatric population.

To address this gap, the team turned to a diabetes prospective follow-up registry containing 25 years of longitudinal data collected from paediatric diabetes centres across Germany. From this resource they identified 45,569 children with type 1 diabetes, 55 percent of them male, with an average age of 10.3 years, whose carbohydrate intake had been recorded at least twice over a period of a year or more. This scale makes the analysis the largest of its kind ever performed, dwarfing previous investigations by orders of magnitude and providing the statistical power needed to examine both common outcomes and rare adverse events.

The children were grouped according to the carbohydrate percentage of their estimated energy intake. A very low carbohydrate group, comprising 219 children, consumed less than 10 percent of their energy from carbohydrate. A low carbohydrate group of 4,837 children obtained between 10 and less than 26 percent. The remaining 40,513 children followed a standard or higher carbohydrate diet of at least 26 percent. Average follow-up periods were 2.18 years for the very low carbohydrate group, 2.40 years for the low carbohydrate group and 3.67 years for the standard carbohydrate group. The researchers tracked height and weight, adjusting for the fact that the children were still growing, alongside changes in glycaemic trajectories, insulin use and the rates of the two most feared severe metabolic complications of diabetes: hypoglycaemia and diabetic ketoacidosis.

The analysis did not flag up any safety concerns in the areas examined. There was no evidence that a very low carbohydrate diet stunted growth, and no association between very low carbohydrate intake and either severe hypoglycaemia or diabetic ketoacidosis. This absence of harm signals is significant because both complications represent the principal acute dangers of type 1 diabetes. Severe hypoglycaemia, in which blood glucose falls to dangerously low levels, can cause seizures, loss of consciousness and, in extreme cases, death. Diabetic ketoacidosis arises when the body, starved of insulin, begins breaking down fat at an uncontrolled rate, producing acidic ketone bodies that overwhelm the blood’s buffering capacity and can rapidly become fatal without emergency treatment. Critics of carbohydrate restriction have long argued that pushing children into a state of relative ketosis might tip vulnerable patients toward ketoacidosis, but the registry data found no support for that fear.

On the benefit side, lower carbohydrate intake was associated with several favourable changes. Body mass index increased less over time in children following very low and low carbohydrate diets than in those on standard diets, meaning their weight remained closer to a healthier range as they grew. Levels of HbA1c, the laboratory measure that reflects average blood sugar over the preceding two to three months, were lower at the end of follow-up and rose less steeply over time in the lower carbohydrate groups. Doses of basal insulin, one of the two types of insulin typically prescribed for type 1 diabetes, followed the same pattern, being lower at the end of the observation period and increasing less over time among children eating less carbohydrate.

Most notably, the study examined a composite metric known as IDAA1c, which combines blood sugar levels with the amount of insulin a person requires. Dr Lennerz explained the significance of this measure: a lower IDAA1c means that better blood sugar control was achieved without simply using more insulin, strengthening the finding that very low and low carbohydrate diets were associated with both better glycaemic control and lower insulin requirements. This distinction matters because a patient could in principle achieve normal glucose readings by escalating insulin doses, but doing so increases the risk of hypoglycaemia and weight gain. A dietary approach that improves glucose control while simultaneously reducing insulin need therefore represents a genuinely favourable metabolic profile rather than a trade-off between competing risks.

The analyses were adjusted for factors including sex, age, migration background and diabetes duration, but the authors caution that the observational design leaves room for residual confounding. Families who choose very low carbohydrate diets may differ from other families in ways the registry cannot fully capture, including health consciousness, socioeconomic resources and the accuracy of self-reported dietary intake. Dr Lennerz concluded that reducing carbohydrate intake improved glycaemic control while reducing insulin needs without negatively impacting growth or increasing the rate of acute diabetes complications, describing the results as very encouraging but emphasising that they remain observational in nature. Additional research, she said, is needed to confirm the findings and establish the ideal amount of carbohydrate intake to maximise benefits while avoiding adverse effects and promoting food variety. For now, the study offers the strongest evidence yet that carbohydrate restriction in children with type 1 diabetes is not the hazard many clinicians feared, while leaving open the question of where the optimal balance lies.

Subject of Research: Effects of very low carbohydrate diets on growth and metabolic safety in children with type 1 diabetes

Article Title: Very low carbohydrate diets linked to health benefits in children with type 1 diabetes, largest study of its kind finds

Article References: Very low carbohydrate diets linked to health benefits in children with type 1 diabetes, largest study of its kind finds. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: type 1 diabetes, very low carbohydrate diet, paediatrics, HbA1c, IDAA1c, insulin requirement, hypoglycaemia, diabetic ketoacidosis, growth, registry study, EASD, nutrition